AstraZeneca and The Medicines Company Company Profile
AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
News Articles
AstraZeneca Sponsors 2013 BIO International Convention, Apr 22 - 25, 2013, in Chicago IL, US
Press Kit Materials are Available at: http://www.tradeshownews.com/events/2013-BIO-International-Convention/AstraZeneca/ Company:...
Pharmaron, a Beijing CRO, Announces Partnership with AstraZeneca
Pharmaron, China’s third-largest CRO, announced a multi-year drug discovery partnership with AstraZeneca that will support AstraZeneca’s global Innovative Medicines Units. Pharmaron will...
Judgment in Case C-457/10 P AstraZeneca v Commission
Luxembourg, 6 December 2012--The Court dismisses the appeal of the AstraZeneca group, which abused its dominant position by preventing the marketing of generic products replicating Losec AstraZeneca A...
Merck, AstraZeneca amend long-standing partnership
Drugmakers Merck & Co. and AstraZeneca PLC have amended their U.S. partnership to give AstraZeneca a 2014 buyout option that could cost more than $400 million.The companies said Wednesday that London-...
AstraZeneca and Pharmacon in a pact to accelerate drug discovery
Pharmaron announced a drug discovery partnership with AstraZeneca to support their global Innovative Medicines Units. Under this multi-year agreement, Pharmaron will provide AstraZeneca with discovery...
AstraZeneca collaborates with Lead Discovery Center for human diseases
The Lead Discovery Center and AstraZeneca have joined forces to discover new medicines for the treatment of human diseases with high unmet medical need. Through a two-year collaboration, AstraZeneca w...
Proffice and AstraZeneca Plan to Extend Their Relationship
Proffice has been appointed by AstraZeneca as its Managed Service Provider for all staffing services for AstraZeneca's operations in Sweden. Based on this, AstraZeneca and Proffice have agreed to ...
AstraZeneca strikes deal with MRC Technology
Drug firm AstraZeneca has struck a deal with London-based MRC Technology, the commercialisation company for the UK's Medical Research Council, to share compounds in the search for new treatments...
Drugs and Medications
Terbinafine hydrochloride [Aurobindo Pharma Limited]
These highlights do not include all the information needed to use terbinafine hydrochloride safely and effectively. See full prescribing information for terbinafine hydrochloride tablets.Terbinafine H...
Rhinocort aqua [AstraZeneca LP]
These highlights do not include all the information needed to use RHINOCORT AQUA Nasal Spray safely and effectively. See full prescribing information for RHINOCORT AQUA Nasal Spray. RHINOCORT AQUA 32...
Walgreen Co. Cimetidine 200 Drug Facts
Dg health heartburn relief [Dolgencorp, LLC]
Dolgencorp, LLC Heartburn Relief Drug Facts
Acid reducer [Rite Aid Corporation]
Rite Aid Corporation Acid Reducer Drug Facts
PubMed Articles
Spirocyclic compounds, potent CCR1 antagonists.
Conformationally constrained spirocycles (17-23) and (31-36) were synthesised. In vitro data revealed that these compounds are CCR1 antagonists with sub-nanomolar potency. In a functional assay 22, 23...
Spiro-fused Pyrrolidine, Piperidine, and Oxindole Scaffolds from Lactams.
Expedient routes to three classes of novel spiro-fused pyrrolidine, piperidine, and indoline heterocycle scaffolds are described. These three-dimensional frameworks, which conform to the "rule of thre...
Literature Review January-March 2011.
The Discovery of MMP7 Inhibitors Exploiting a Novel Selectivity Trigger.
Clinical Trials
Tuberculosis Treatment Shortening Trial
Tuberculosis (TB) is a serious infection that can affect the lungs and other parts of the body. The usual way to treat TB is to take 4 medicines by mouth every day for 2 months, then take...
Esomeprazole Bioavailability Study With 40 mg Oral Single Dose Fasted and Fed Administration
The present study will be conducted in order to compare the bioavailability of 40 mg Esomeprazole Mepha (Mepha Ltd., Switzerland) and of INexium 40 mg MUPS tablets (AstraZeneca, France) un...
The National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG) has informed AstraZeneca that the BR24 Phase II/III study of cediranib at 30mg in first line non-small cell lung ca...
Drug Interaction Study Between Antimalarial and Anti-HIV Medications
The purpose of this study is to find out whether taking certain anti-HIV medicines with certain antimalarial medicines affects the amount of the medicines in the blood. The study medicine...
Strategic Timing of Antiretroviral Treatment
Objectives: - To find out if the chance of developing a serious illness or of getting AIDS is less if patients start taking HIV medicines at a time when their CD4+ cell count is s...
Companies
AstraZeneca and The Medicines Company
AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines for gastro...
AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines. As a leader in gastrointestin...
AstraZeneca Pharmaceuticals LP
AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines. As a lead...
AstraZeneca HealthCare Foundation
Established in 1993, the AstraZeneca HealthCare Foundation is a Delaware not-for-profit corporation and a 501(c)(3) entity organized for charitable purposes including to promote p...
AstraZeneca er et av verdens ledende farmasøytiske selskaper. Vi bruker hvert år ca. 25 milliarder norske kroner på forskning verden over for å utvikle nye medisiner. Dette har resultert i en rekk...
More Information about "AstraZeneca and The Medicines Company" on BioPortfolio
We have published hundreds of AstraZeneca and The Medicines Company news stories on BioPortfolio along with dozens of AstraZeneca and The Medicines Company Clinical Trials and PubMed Articles about AstraZeneca and The Medicines Company for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AstraZeneca and The Medicines Company Companies in our database. You can also find out about relevant AstraZeneca and The Medicines Company Drugs and Medications on this site too.
